Your browser doesn't support javascript.
loading
Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study.
Shen, Xia-Bo; Li, Guang-Liang; Zheng, Ya-Bing; Chen, Zhan-Hong; Cao, Wen-Ming; Wang, Xiao-Jia; Shao, Xi-Ying.
Affiliation
  • Shen XB; Department of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
  • Li GL; Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Zheng YB; Department of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
  • Chen ZH; Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Cao WM; Department of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
  • Wang XJ; Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Shao XY; Department of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Ann Transl Med ; 9(16): 1334, 2021 Aug.
Article de En | MEDLINE | ID: mdl-34532471

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Ann Transl Med Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Ann Transl Med Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: Chine